Isconova’s core business is based on using state-of-the-art ISCOM technology to develop innovative and more efficacious vaccines together with vaccine development partners.

We are convinced that these opportunities are best transformed into concrete achievements in collaboration with partners and customers who contribute their own respective core competences.

Our ISCOM technology has already been utilized in many successful projects and has resulted in a number of success stories. Five vaccines are currently launched on the veterinary market, for example, and more are expected to follow.

To maximize what can be achieved with this technology, we combine our adjuvant experience and expertise with your core vaccine competence in well-defined collaboration models.

To help you achieve success in your vaccine development project, we suggest you take a look at our step-wise collaboration guidelines.